Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Arthritis & Rheumatism

• Publication date

  2009-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.24735PMID 19790131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reflections on amyloidosis in Papua New Guinea

  2008cited by this paper
• Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis

  2008cited by this paper
• Amyloidosis is frequently undetected in patients with rheumatoid arthritis

  2008cited by this paper
• Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes1

  2008cited by this paper
• Amyloidosis as a cause of death in patients with rheumatoid arthritis.

  2008cited by this paper
• AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes

  2008cited by this paper
• Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.

  2008cited by this paper
• A systems biology approach to construct the gene regulatory network of systemic inflammation via microarray and databases mining

  2008cited by this paper
• SAA1 α/α alleles in Behçet’s disease related amyloidosis

  2007cited by this paper
• Natural history and outcome in systemic AA amyloidosis.

  2007cited by this paper
• Variant mannose‐binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis

  2007cited by this paper
• Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A.

  2007cited by this paper
• Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model

  2007cited by this paper
• SAA1 alpha/alpha alleles in Behçet's disease related amyloidosis.

  2007cited by this paper
• Prevalence of subclinical amyloidosis in ankylosing spondylitis.

  2007cited by this paper
• Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

  2007cited by this paper
• Mannose-binding lectin and its genetic variants

  2006cited by this paper
• Aging in heterozygous Dnmt1-deficient mice: effects on survival, the DNA methylation genes, and the development of amyloidosis.

  2006cited by this paper
• Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.

  2006cited by this paper
• Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis

  2006cited by this paper
• Metalloendoprotease cleavage triggers gelsolin amyloidogenesis

  2005cited by this paper
• Relative transcriptional activities of SAA1 promoters polymorphic at position −13(T/C): Potential association between increased transcription and amyloidosis

  2005cited by this paper
• In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

  2005cited by this paper
• Generation of Amyloid A Protein by the Cell Lines from Amyloid‐Susceptible and ‐Resistant Mice

  2004cited by this paper
• Humoral Proinflammatory Cytokine and SAA Generation Profiles and Spatio‐Temporal Relationship Between SAA and Lysosomal Cathepsin B and D in Murine Splenic Monocytoid Cells During AA Amyloidosis

  2004cited by this paper
• Characterization of Splenic Glycosaminoglycans Accumulated In Vivo in Experimentally Induced Amyloid‐Susceptible and Amyloid‐Resistant Mice

  2004cited by this paper
• Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages

  2004cited by this paper
• SAA1 Gene Analysis in Finnish Patients with AA Amyloidosis

  2004cited by this paper
• The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever.

  2003cited by this paper
• An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians

  2003cited by this paper
• Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis.

  2003cited by this paper
• Slower clearance of human SAA1.5 in mice: Implications for allele specific variation of SAA concentration in human

  2003cited by this paper
• Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.

  2003cited by this paper
• Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis

  2002cited by this paper
• A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid.

  2002cited by this paper
• Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics

  2001cited by this paper
• A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.

  2001cited by this paper
• Serum Amyloid A (apoSAA) Expression Is Up-Regulated in Rheumatoid Arthritis and Induces Transcription of Matrix Metalloproteinases

  2001cited by this paper
• Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

  2001cited by this paper
• Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis

  2001cited by this paper
• The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration.

  2001cited by this paper
• Impaired degradation of serum amyloid A (SAA) protein by cytokine‐stimulated monocytes

  2001cited by this paper
• Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and α2-macroglobulin in cases of generalized AA- and AL amyloidosis

  2000cited by this paper
• Expression of Mouse Apolipoprotein SAA1.1 in CE/J Mice: Isoform-Specific Effects on Amyloidogenesis

  2000cited by this paper
• Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis

  1999cited by this paper
• The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A

  1999cited by this paper
• SAA1 alleles as risk factors in reactive systemic AA amyloidosis.

  1998cited by this paper
• Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDLSAA) donors by murine macrophages of four different mouse strains

  1998cited by this paper
• Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration.

  1997cited by this paper
• Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis

  1997cited by this paper
• Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin.

  1996cited by this paper
• Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy.

  1996cited by this paper
• Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

  1995cited by this paper
• Cathepsin B Generates the Most Common Form of Amyloid A (76 Residues) as a Degradation Product from Serum Amyloid A

  1995cited by this paper
• Characterization of the inbred CE/J mouse strain as amyloid resistant.

  1993cited by this paper
• Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions

  1992cited by this paper
• Impaired Kupffer cell function precedes development of secondary amyloidosis

  1985cited by this paper
• Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes

  1978cited by this paper
• On the formation and disappearance of amyloid in man

  1928cited by this paper
• The FASEB Journal express article 10.1096/fj.03-1436fje. Published online September 2, 2004.

  year unknowncited by this paper

• Systemic Amyloidosis Secondary to Psoriasis: A Rare, Autoimmune and Genetically-Determined Disorder That Is Amenable to Treatment with Cyclosporin A<br>&#8212;Cyclosporin A for Psoriasis-Induced Amyloidosis

  2024cites this paper
• bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease

  2024cites this paper
• Amyloidosis and Amyloidogenesis: One Name, Many Diseases.

  2024cites this paper
• Secondary AA-amyloidosis in pediatric and adult patients: classification, etiology, pathogenesis, diagnosis, treatment

  2023cites this paper
• Autoinflammatory diseases and the kidney

  2023cites this paper
• Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

  2023cites this paper
• Macrophages in the reticuloendothelial system inhibit early induction stages of mouse apolipoprotein A-II amyloidosis

  2022cites this paper
• Development of a radioiodinated thioflavin-T-Congo-red hybrid probe for diagnosis of systemic amyloidosis.

  2022cites this paper
• Risk factors for developing renal amyloidosis

  2022cites this paper
• Gout and AA-Amyloidosis: A Case-Based Review

  2021cites this paper
• Epidemiology of Amyloidosis and Genetic Pathways to Diagnosis and Typing

  2021cites this paper
• Epidémiologie des amyloses cardiaques

  2021cites this paper
• Natural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent fevers

  2021cites this paper
• Oxazolone-induced gastrointestinal disorders enhance the oral transmission of AA amyloidosis in mice

  2021cites this paper
• Epidemiology and clinical manifestations of cardiac amyloidosis

  2021cites this paper
• Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides)

  2020cites this paper
• Amyloid in the Lung

  2020cites this paper
• Prevalence of Subclinical Amyloidosis in a Cross-sectional Study of Egyptian RA Patients without Proteinuria.

  2019cites this paper
• Causes of AA amyloidosis: a systematic review

  2019cites this paper
• Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review

  2019cites this paper
• Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease—A review

  2019cites this paper
• Olive Leaf Extract Attenuates Inflammatory Activation and DNA Damage in Human Arterial Endothelial Cells

  2019cites this paper
• Acute phase reactant serum amyloid A in inflammation and other diseases.

  2019cites this paper
• Multiple nodular pulmonary amyloidosis in a patient with rheumatoid arthritis

  2019cites this paper
• Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.

  2018cites this paper
• First case of pleural amyloidosis in systemic erythematosus: report and literature review

  2018cites this paper
• Secondary, AA, Amyloidosis.

  2018cites this paper
• Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damage.

  2018cites this paper
• The Clinical Spectrum of Amyloidosis

  2018cites this paper
• [Autoinflammatory diseases and kidney involvement].

  2017cites this paper
• A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis.

  2017cites this paper
• Dental conditions in rheumatic diseases.

  2017cites this paper
• [A rare concurrence of polymyalgia rheumatica and AA-amyloidosis].

  2017influential citation
• Cystic Fibrosis: A Risk Condition for Renal Disease.

  2017cites this paper
• Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report

  2017cites this paper
• Amyloidosis – short review

  2016cites this paper
• Carbamylation of the amino‐terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model

  2016cites this paper
• Caso Clínico: Amiloidosis Primaria Renal, Diagnóstico Clínico.

  2016cites this paper
• Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases

  2016cites this paper
• Amyloidosis enhancing activity of bovine amyloid A fibrils in C3H/HeN mice and cynomolgus monkeys (Macaca fascicularis)

  2016cites this paper
• Importance of serum amyloid-A in Behçet’s disease

  2016cites this paper
• A study on the association between serum amyloid A and sperm concentration

  2016cites this paper
• Developments in the Treatment of Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis

  2016cites this paper
• Evaluation of Serum Amyloid A as a Marker of Persistent Inflammation in Patients with Rheumatoid Arthritis

  2015cites this paper
• Evaluation of serum amyloid-A as mortality predictor in continuous ambulatory peritoneal dialysis patients

  2015cites this paper
• Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis

  2015cites this paper
• Emerging treatments for amyloidosis.

  2015cites this paper
• Lupus eritematoso sistémico y amiloidosis: una asociación poco frecuente

  2015cites this paper
• Importance of serum amyloid A on the diagnosis of acute appendicitis.

  2015cites this paper
• Amiloidosis sistémica secundaria AA

  2015cites this paper
• Amyloidosis in alkaptonuria

  2015cites this paper
• [Systemic secondary AA amyloidosis].

  2015cites this paper
• Long‐term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice

  2015cites this paper
• Systemic secondary AA amyloidosis

  2015cites this paper
• Long-Term Complications of Familial Mediterranean Fever

  2015cites this paper
• Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis

  2014cites this paper
• Systemic AA amyloidosis: epidemiology, diagnosis, and management

  2014cites this paper
• Failure of heterogeneous amyloid‐enhancing factor in geriatric squirrel monkeys (Saimiri boliviensis)

  2014cites this paper
• Incidence of Tuberculosis and Amyloidosis among Sudanese Patients Presented with Enlarged Nodes

  2014cites this paper
• Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer.

  2014cites this paper
• Vasculitic Neuropathies and Neuropathies of Connective Tissue Diseases

  2014cites this paper
• Diagnosis of secondary amyloidosis in alkaptonuria

  2014cites this paper
• Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.

  2014cites this paper
• Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis

  2013cites this paper
• Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases

  2013cites this paper
• Efficient amyloid A clearance in the absence of immunoglobulins and complement factors.

  2013cites this paper
• Pathophysiology and treatment of systemic amyloidosis

  2013cites this paper
• Therapeutic Strategies in Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis

  2013cites this paper
• Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium

  2013cites this paper
• Control of AA amyloidosis complicating Crohn's disease: a clinico‐pathological study

  2013cites this paper
• AA amyloidosis in vaccinated growing chickens.

  2013cites this paper
• Decreasing incidence of AA amyloidosis in Spain

  2013cites this paper
• The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review.

  2013cites this paper
• Molecular Genetics of Alkaptonuria

  2013cites this paper
• Amyloid Diseases at the Molecular Level: General Overview and Focus on AL Amyloidosis

  2012cites this paper
• Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine.

  2012cites this paper
• Serum amyloid A – an acute-phase protein involved in systemic sclerosis pathogenesis?

  2012influential citation
• Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease

  2012cites this paper
• Autoinflammation and autoimmunity: bridging the divide.

  2012cites this paper
• Small molecules that target protein misfolding.

  2012cites this paper
• Alkaptonuria is a novel human secondary amyloidogenic disease

  2012cites this paper
• Cheetahs have 4 serum amyloid a genes evolved through repeated duplication events.

  2012cites this paper
• Plasma proteomics of differential outcome to long‐term therapy in children with idiopathic pulmonary arterial hypertension

  2012cites this paper
• Systemic AA amyloidosis.

  2012cites this paper
• Amyloidosis in autoinflammatory syndromes.

  2012cites this paper
• 2 Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis

  2012cites this paper
• Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?

  2012influential citation
• Rheumatic heart disease associated with secondary renal amyloidosis.

  2012cites this paper
• Incidence and survival in non-hereditary amyloidosis in Sweden

  2012cites this paper
• AA amyloidosis: basic knowledge, unmet needs and future treatments.

  2012cites this paper
• A case of systemic amyloidosis associated with cyclic neutropenia

  2011cites this paper
• Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency

  2011cites this paper
• Successful use of Tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis

  2011cites this paper
• AA amyloidosis associated with hepatitis B.

  2011cites this paper
• Diagnosis and Treatment of AA Amyloidosis with Rheumatoid Arthritis: State of the Art

  2011cites this paper
• Reducing the amyloid burden through immunotherapy: a major therapeutic advance.

  2011cites this paper
• Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis

  2011cites this paper
• Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents

  2011cites this paper
• Tocilizumab for the Treatment of AA Amyloidosis

  2011cites this paper
• Pathogenesis of experimental amyloid protein A amyloidosis in sore hocks-affected rabbits

  2011cites this paper